Clinical Registry on Sudden Death Primary Prevention at Latin America — ESCAPE-ICD  

Myocardial Infarction Clinical Trial

Official title: Clinical Registry on Sudden Death Primary Prevention at Latin America (rEgiStro Clinico en America Latina de Prevencion Primaria en muErte Subita)

Status Withdrawn

Clinical Trial Summary

INTRODUCTION: Sudden cardiac death is one of the most important reasons of death at industrialized countries. Despite its importance, nowadays Clinical Guidelines are not as extended as expected, with respect to indications for primary prevention defibrillator implantation, following MADIT II and MUSTT criteria, especially at Latin American countries.

OBJECTIVES: This Project is designed with the purpose of providing tools to help spreading primary prevention by the means of clinical evidence on real risk of death in this group of patients.

REGISTRY DESIGN:

• retrospective (at stage 1); prospective (at stage 2)

• multi-center (minimum 25-30 centres)

• international (Argentina, Brazil, Colombia, Chile, Mexico and Venezuela)

• non randomized.

• Sample size: at screening about 12.500 patients and 962 patients at treatment stage

REGISTRY DEVICES: CE marked (Conformité Européenne) single-chamber, dual-chamber or CRT (Cardiac Resynchronization Therapy) implantable cardiac defibrillator (ICD).

Clinical Trial Description

REGISTRY STAGES 2 stages will be performed:

• Stage 1 (Screening): 12500 patients with MI and LVEF<40% will be evaluated, to know ICD implantation prevalence in such patients at Latin American countries

• Stage 2 (Treatment): after patient screening and as per clinical decision, 962 patients will be entered in group 1 and 2 (481 each, 1:1)

STEERING COMMITTEE

• Dr. Sergio Dubner. Clinica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires - Argentina

• Dr. William Uribe. CES CARDIOLOGIA. Medellin - Colombia

CLINICAL ASSESSMENT

• Dr Francisco Javier Alzueta Rodriguez. Hospital Clinico Universitario Virgen de la Victoria. Malaga - Spain

REGISTRY DURATION

• Patient enrollment period initiation: September 2011

• End of patient enrollment: September 2013

• End of FUs: September 2018

• Registry closure and data analyses: 4Q 2018.

REGULATORY CONSIDERATIONS As this is an observational registry, no submission to National Authorities is required. ;

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Death
• Death, Sudden
• Infarction
• Myocardial Infarction
• Sudden Death

• NCT number: NCT01422174
• Study type: Observational
• Source: Biotronik SE & Co. KG
• Status: Withdrawn
• Phase: N/A
• Start date: March 2012
• Completion date: January 2015